When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Erythema infectiosum

Evidence last reviewed: 14 Sep 2026
Topic last updated: 19 May 2026

Summary

Definition

History and exam

Key diagnostic factors

  • close contact with other infected individuals
  • bright red macular erythema of the bilateral cheeks with sparing of the nasal ridge and perioral areas
  • erythematous macules and papules evolving into lacy reticular erythema, most notable on the extremities
  • immunodeficiency
Full details

Other diagnostic factors

  • arthralgia/arthritis
  • prodrome (fever, headache, pharyngitis, coryza, abdominal pain)
  • symptoms of anemia
Full details

Risk factors

  • close contact with other infected individuals
  • immunodeficiency
  • age 6 to 10 years
Full details

Diagnostic tests

1st tests to order

  • clinical diagnosis
Full details

Tests to consider

  • CBC
  • reticulocyte count
  • serology
  • DNA assays
Full details

Treatment algorithm

ACUTE

fever

secondary arthritis

ONGOING

persistent (>3 weeks) parvovirus B19 infection

Contributors

Authors

Joseph M. Lam, MD

Clinical Professor, Department of Pediatrics

Associate Member, Department of Dermatology and Skin Sciences

University of British Columbia, BC Children’s Hospital

Vancouver

BC

Canada

Declarações

JML declares that he has no relevant competing interests.

Alexander K. C. Leung, MD

Department of Pediatrics

The University of Calgary, Alberta Children's Hospital

Calgary

Alberta

Canada

Declarações

AKCL declares that he has no relevant competing interests.

Agradecimentos

Dr Joseph M. Lam and Dr Alexander Leung would like to gratefully acknowledge Dr Kari L. Martin, Dr Christine T. Lauren, Dr Jon Dyer, and Dr Jennifer Holman, the previous contributors to this topic. KLM has served as a board member for Women's Dermatologic Society and American Contact Dermatitis Society. CTL, JD, and JH declare that they have no competing interests.

Revisores

Ganga Moorthy, MD, MSc-GH

Assistant Professor

Pediatric Infectious Diseases

Duke University Medical Center

Durham, NC

Declarações

GM declares that she has no competing interests.

Nevio Cimolai, MD

Professor

Department of Pathology and Laboratory Medicine

Children's and Women's Health Centre of British Columbia

Vancouver

Canada

Declarações

NC declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350:586-597. Resumo

UK Health Security Agency. Parvovirus B19: guidance, data and analysis. Aug 2024 [internet publication].Texto completo

Kimberlin DW, Banerjee R, Barnett ED, et al. Red book: 2024-2027 report of the Committee on Infectious Diseases. 33rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2024.

Centers for Disease Control and Prevention. Parvovirus B19 and fifth disease: about parvovirus B19. Dec 2025 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal